Bo Fu
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- RNA modifications and cancer 4
-
- Hepatitis C virus research 6
- Co-authors
- Deborah Symmons (2 shared papers)Mark Lunt (2 shared papers)Kimme L Hyrich (2 shared papers)William G Dixon (1 shared paper)James Galloway (1 shared paper)Andrew Ustianowski (1 shared paper)Louise Mercer (1 shared paper)Kath Watson (1 shared paper)
- Journals
- Journal of Hepatology (4 papers)Scientific Reports (4 papers)Human Pathology (2 papers)Life (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bo Fu
40 papers receiving 992 citations
Bo Fu's Hit Papers
Peers
Comparison fields: 5 of 103
- Rheumatology 317
- Hematology 85
- Hepatology 48
- Cancer Research 91
- Immunology 107
Countries citing papers authored by Bo Fu
This map shows the geographic impact of Bo Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Fu more than expected).
Fields of papers citing papers by Bo Fu
This network shows the impact of papers produced by Bo Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Fu. The network helps show where Bo Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly Hit paper breakdown → | 2010 | 502 |
| 2 | 2021 | 86 | |
| 3 | 2015 | 41 | |
| 4 | 2017 | 39 | |
| 5 | 2013 | 37 | |
| 6 | 2015 | 26 | |
| 7 | 2018 | 23 | |
| 8 | 2014 | 20 | |
| 9 | 2014 | 20 | |
| 10 | 2023 | 19 | |
| 11 | 2011 | 18 | |
| 12 | 2016 | 18 | |
| 13 | 2013 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 12 | |
| 16 | 2016 | 12 | |
| 17 | 2014 | 11 | |
| 18 | 2021 | 9 | |
| 19 | 2014 | 9 | |
| 20 | 2023 | 8 |
About Bo Fu
Bo Fu is a scholar working on Molecular Biology, Hepatology, Infectious Diseases, Pathology and Forensic Medicine and Rheumatology, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (6 papers), HIV/AIDS drug development and treatment (4 papers), RNA modifications and cancer (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Syphilis Diagnosis and Treatment (2 papers), Systemic Lupus Erythematosus Research (2 papers), Lung Cancer Research Studies (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Rheumatology (317 citations), Hematology (85 citations), Hepatology (48 citations), Cancer Research (91 citations) and Immunology (107 citations). Bo Fu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Deborah Symmons, Mark Lunt, Kimme L Hyrich, William G Dixon, James Galloway, Andrew Ustianowski, Louise Mercer, Kath Watson, Anqi Zhang and Wenqiang Tang. Their work appears in journals such as Journal of Hepatology, Scientific Reports, Human Pathology, Life and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.